Roth CH(ROCH)

28.9 %

今开:28.9昨收:28.9
最高:28.9最低:28.9
涨停价:跌停价:
总市值:284029200

Roth CH的热门评论

罗氏双抗治疗DME两项III期临床达主要终点,显示强大持久性

andrewmed2020-12-22 09:30

文章来源:“凯莱英药闻”微信公众号 2020年12月21日,罗氏旗下基因泰克公布了两项设计相同的全球III期临床试验YOSEMITE和RHINE的积极顶线结果,研究评估了在研双特异性抗体Faricimab在糖尿病性黄斑水肿(DME)患者中的作用。 两项研究均达到主要终点,与每8周给药一次的阿柏西普相比,每8周给药...

Roth CH(ROCH)03-18 04:27

$Roth CH(ROCH)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-21-000359 Act: 34 Size: 2 KB 网页链接

Roth CH的最新评论

Roth CH(ROCH)03-18 04:27

$Roth CH(ROCH)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-21-000359 Act: 34 Size: 2 KB 网页链接查看全文

罗氏双抗治疗DME两项III期临床达主要终点,显示强大持久性

andrewmed2020-12-22 09:30

文章来源:“凯莱英药闻”微信公众号 2020年12月21日,罗氏旗下基因泰克公布了两项设计相同的全球III期临床试验YOSEMITE和RHINE的积极顶线结果,研究评估了在研双特异性抗体Faricimab在糖尿病性黄斑水肿(DME)患者中的作用。 两项研究均达到主要终点,与每8周给药一次的阿柏西普相比,每8周给药...查看全文

Roth CH的公告

$Roth CH(ROCH)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-21-000359 Act: 34 Size: 2 KB 网页链接

$Roth CH(ROCH)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000919574-21-002265 Act: 34 Size: 157 KB 网页链接

$Roth CH(ROCH)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001104659-21-033698 Act: 34 Size: 3 MB 网页链接

$Roth CH(ROCH)$ DEFM14A Definitive proxy statement relating to merger or acquisition Accession Number: 0001104659-21-021022 Act: 34 Size: 8 MB 网页链接

$Roth CH(ROCH)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-21-016908 Act: 34 Size: 35 KB 网页链接

$Roth CH(ROCH)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001389277-21-000004 Act: 34 Size: 19 KB 网页链接

$Roth CH(ROCH)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-20-125779 Act: 34 Size: 61 KB 网页链接

$Roth CH(ROCH)$ 425 Prospectuses and communications, business combinations Accession Number: 0001104659-20-125418 Act: 34 Size: 20 MB 网页链接

$Roth CH(ROCH)$ 8-K Current report, items 1.01, 3.02, 7.01, and 9.01 Accession Number: 0001104659-20-125417 Act: 34 Size: 20 MB 网页链接